newsfilter
← Latest News
PR Newswire·

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel

SK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and Israel PANGYO, South Korea, Aug. 9, 2022 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin